APVO as of Nov 4 · 03:55 ET
APVONasdaqPharmaceutical Preparations
Aptevo Therapeutics Inc. · Brief
Next report
1 day
Nov 5 · after closeest.Q3 FY26
Expected move
No implied move.
—≥ implied
Q2 FY26—▼−13.53%—
quarterimplied−15%0+15%realized×
Q2 FY26—▼−13.53%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.—
Linked exposure
APVO report sessionNo linked exposure.
Oct 238-KMaterial agreement: Amendment to the Rights Agreement with Broadridge Corporate Issuer Solutions, LLC.Source
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.